Followers | 507 |
Posts | 10138 |
Boards Moderated | 0 |
Alias Born | 04/28/2014 |
Wednesday, April 22, 2015 12:04:48 PM
bullish
## source: finance.yahoo.com
Wed, 22 Apr 2015 12:14:03 GMT ~ BioTime Licenses Beckman Research Institute of City of Hope to Manufacture Clinical Grade Stem Cells
[at noodls] - BioTime Licenses Beckman Research Institute of City of Hope to Manufacture Clinical Grade Stem Cells ALAMEDA, Calif.--(BUSINESS WIRE)--Apr. 22, 2015-- BioTime, Inc. (NYSE MKT: BTX) today announced a nonexclusive ...
read full: http://www.noodls.com/view/26ECBA49DC1E74341EEA9FDCB31BD084DFD65588
*********************************************************
Wed, 22 Apr 2015 12:03:00 GMT ~ 8:03 am BioTime licenses Beckman Research Institute of City of Hope to manufacture clinical grade stem cells
read full: http://finance.yahoo.com/news/inplay-briefing-com-055139997.html#btx
*********************************************************
Wed, 22 Apr 2015 12:00:00 GMT ~ BioTime Licenses Beckman Research Institute of City of Hope to Manufacture Clinical Grade Stem Cells
[Business Wire] - ALAMEDA, Calif.--(BUSINESSWIRE)-- BioTime, Inc. (NYSE MKT: BTX) today announced a nonexclusive License Agreement between BioTime’s subsidiary ES Cell International Pte Ltd (ESI) and Beckman Research Institute of the City of Hope (BRICOH, Duarte, CA) through which ESI’s clinical-grade human embryonic stem (hES) cells will be manufactured and provided to BRICOH’s clinical collaborators, including medical research organizations intent on using the hES cells to develop and commercialize therapeutic products to treat human disease. The Agreement is a critical part of BioTime’s strategy to leverage third party funding and generate future revenues by placing its hES cells in programs developing a wide array of therapeutic applications made possible with pluripotent stem cell technology, products that are currently not being developed by BioTime or its subsidiaries. Successful medical research organizations will need to obtain separate licenses from BioTime in order to advance their products based on ESI’s hES cells into clinical trials and commercialization.
read full: http://au.finance.yahoo.com/news/biotime-licenses-beckman-research-institute-120000274.html
*********************************************************
Wed, 22 Apr 2015 12:00:00 GMT ~ BioTime Licenses Beckman Research Institute of City of Hope to Manufacture Clinical Grade Stem Cells
[Business Wire] - BioTime, Inc. today announced a nonexclusive License Agreement between BioTime’s subsidiary ES Cell International Pte Ltd and Beckman Research Institute of the City of Hope through which ESI’s clinical-grade human embryonic stem cells will be manufactured and provided to BRICOH’s clinical collaborators, including medical research organizations intent on using the hES cells to develop and commercialize ...
read full: http://finance.yahoo.com/news/biotime-licenses-beckman-research-institute-120000042.html
*********************************************************
Tue, 21 Apr 2015 12:01:08 GMT ~ BIOTIME INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits
read full: http://biz.yahoo.com/e/150421/btx8-k.html
*********************************************************
$BTX charts
basic chart ## source: stockcharts.com
basic chart ## source: stockscores.com
big daily chart ## source: stockcharts.com
big weekly chart ## source: stockcharts.com
$BTX company information
## source: otcmarkets.com
Link: http://www.otcmarkets.com/stock/BTX/company-info
Ticker: $BTX
OTC Market Place: Not Available
CIK code: 0000876343
Company name: BioTime, Inc.
Company website: http://www.biotimeinc.com
Incorporated In: CA, USA
$BTX share structure
## source: otcmarkets.com
Market Value: $453,193,589 a/o Apr 21, 2015
Shares Outstanding: 83,154,787 a/o Mar 09, 2015
Float: Not Available
Authorized Shares: Not Available
Par Value: No Par Value
$BTX extra dd links
Company name: BioTime, Inc.
Company website: http://www.biotimeinc.com
## STOCK DETAILS ##
After Hours Quote (nasdaq.com): http://www.nasdaq.com/symbol/BTX/after-hours
Option Chain (nasdaq.com): http://www.nasdaq.com/symbol/BTX/option-chain
Historical Prices (yahoo.com): http://finance.yahoo.com/q/hp?s=BTX+Historical+Prices
Company Profile (yahoo.com): http://finance.yahoo.com/q/pr?s=BTX+Profile
Industry (yahoo.com): http://finance.yahoo.com/q/in?s=BTX+Industry
## COMPANY NEWS ##
Market Stream (nasdaq.com): http://www.nasdaq.com/symbol/BTX/stream
Latest news (otcmarkets.com): http://www.otcmarkets.com/stock/BTX/news - http://finance.yahoo.com/q/h?s=BTX+Headlines
## STOCK ANALYSIS ##
Analyst Research (nasdaq.com): http://www.nasdaq.com/symbol/BTX/analyst-research
Guru Analysis (nasdaq.com): http://www.nasdaq.com/symbol/BTX/guru-analysis
Stock Report (nasdaq.com): http://www.nasdaq.com/symbol/BTX/stock-report
Competitors (nasdaq.com): http://www.nasdaq.com/symbol/BTX/competitors
Stock Consultant (nasdaq.com): http://www.nasdaq.com/symbol/BTX/stock-consultant
Stock Comparison (nasdaq.com): http://www.nasdaq.com/symbol/BTX/stock-comparison
Investopedia (investopedia.com): http://www.investopedia.com/markets/stocks/BTX/?wa=0
Research Reports (otcmarkets.com): http://www.otcmarkets.com/stock/BTX/research
Basic Tech. Analysis (yahoo.com): http://finance.yahoo.com/q/ta?s=BTX+Basic+Tech.+Analysis
Barchart (barchart.com): http://www.barchart.com/quotes/stocks/BTX
DTCC (dtcc.com): http://search2.dtcc.com/?q=BioTime%2C+Inc.&x=10&y=8&sp_p=all&sp_f=ISO-8859-1
Spoke company information (spoke.com): http://www.spoke.com/search?utf8=%E2%9C%93&q=BioTime%2C+Inc.
Corporation WIKI (corporationwiki.com): http://www.corporationwiki.com/search/results?term=BioTime%2C+Inc.&x=0&y=0
WHOIS (domaintools.com): http://whois.domaintools.com/http://www.biotimeinc.com
Alexa (alexa.com): http://www.alexa.com/siteinfo/http://www.biotimeinc.com#
Corporate website internet archive (archive.org): http://web.archive.org/web/*/http://www.biotimeinc.com
## FUNDAMENTALS ##
Call Transcripts (nasdaq.com): http://www.nasdaq.com/symbol/BTX/call-transcripts
Annual Report (companyspotlight.com): http://www.companyspotlight.com/library/companies/keyword/BTX
Income Statement (nasdaq.com): http://www.nasdaq.com/symbol/BTX/financials?query=income-statement
Revenue/EPS (nasdaq.com): http://www.nasdaq.com/symbol/BTX/revenue-eps
SEC Filings (nasdaq.com): http://www.nasdaq.com/symbol/BTX/sec-filings
Edgar filings (sec.gov): http://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000876343&owner=exclude&count=40
Latest filings (otcmarkets.com): http://www.otcmarkets.com/stock/BTX/filings
Latest financials (otcmarkets.com): http://www.otcmarkets.com/stock/BTX/financials
Short Interest (nasdaq.com): http://www.nasdaq.com/symbol/BTX/short-interest
Dividend History (nasdaq.com): http://www.nasdaq.com/symbol/BTX/dividend-history
RegSho (regsho.com): http://www.regsho.com/tools/symbol_stats.php?sym=BTX&search=search
OTC Short Report (otcshortreport.com): http://otcshortreport.com/index.php?index=BTX
Short Sales (otcmarkets.com): http://www.otcmarkets.com/stock/BTX/short-sales
Key Statistics (yahoo.com): http://finance.yahoo.com/q/ks?s=BTX+Key+Statistics
Insider Roster (yahoo.com): http://finance.yahoo.com/q/ir?s=BTX+Insider+Roster
Income Statement (yahoo.com): http://finance.yahoo.com/q/is?s=BTX
Balance Sheet (yahoo.com): http://finance.yahoo.com/q/bs?s=BTX
Cash Flow (yahoo.com): http://finance.yahoo.com/q/cf?s=BTX+Cash+Flow&annual
## HOLDINGS ##
Major holdings (cnbc.com): http://data.cnbc.com/quotes/BTX/tab/8.1
Insider transactions (yahoo.com): http://finance.yahoo.com/q/it?s=BTX+Insider+Transactions
Insider transactions (secform4.com): http://www.secform4.com/insider-trading/BTX.htm
Insider transactions (insidercrow.com): http://www.insidercow.com/history/company.jsp?company=BTX
Ownership Summary (nasdaq.com): http://www.nasdaq.com/symbol/BTX/ownership-summary
Institutional Holdings (nasdaq.com): http://www.nasdaq.com/symbol/BTX/institutional-holdings
Insiders (SEC Form 4) (nasdaq.com): http://www.nasdaq.com/symbol/BTX/insider-trades
Insider Disclosure (otcmarkets.com): http://www.otcmarkets.com/stock/BTX/insider-transactions
## SOCIAL MEDIA AND OTHER VARIOUS SOURCES ##
PST (pennystocktweets.com): http://www.pennystocktweets.com/stocks/profile/BTX
Market Watch (marketwatch.com): http://www.marketwatch.com/investing/stock/BTX
Bloomberg (bloomberg.com): http://www.bloomberg.com/quote/BTX:US
Morningstar (morningstar.com): http://quotes.morningstar.com/stock/s?t=BTX
Bussinessweek (businessweek.com): http://investing.businessweek.com/research/stocks/snapshot/snapshot_article.asp?ticker=BTX
$BTX DD Notes ~ http://www.ddnotesmaker.com/BTX
Recent LCTX News
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/09/2024 08:15:44 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/09/2024 08:10:17 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/08/2024 09:05:31 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/08/2024 09:05:28 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/08/2024 09:05:26 PM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 03/07/2024 10:17:24 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/07/2024 09:10:09 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/15/2024 10:27:49 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/13/2024 02:30:12 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/13/2024 02:27:33 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/09/2024 12:00:09 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/08/2024 11:58:18 PM
- Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] • Edgar (US Regulatory) • 02/08/2024 11:57:07 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 02/06/2024 02:25:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/06/2024 02:20:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 02/06/2024 02:00:23 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/03/2024 12:08:49 AM
- Take Part in the Next Generation of Spinal Cord Injury Treatments with These Companies • AllPennyStocks.com • 11/16/2023 09:21:00 PM
- Take Part in the Next Generation of Spinal Cord Injury Treatments with These Companies • AllPennyStocks.com • 11/16/2023 09:21:00 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 11/13/2023 09:19:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/09/2023 09:10:32 PM
- Small Company Working on Big Breakthrough in Treating Spinal Cord Injuries • AllPennyStocks.com • 10/11/2023 02:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/07/2023 09:01:43 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/10/2023 08:16:11 PM
FEATURED POET Announces Design Win and Collaboration with Foxconn Interconnect Technology for High-speed AI Systems • May 14, 2024 10:09 AM
FEATURED Element79 Gold Corp Reports Exceptionally High-Grade Results from Lucero • May 14, 2024 7:00 AM
VAYK Added New Manager for Expansion into $64 Billion Domestic Short-term Rental Market • VAYK • May 14, 2024 9:00 AM
Avant Technologies Equipping AI-Managed Data Center with High Performance Computing Systems • AVAI • May 10, 2024 8:00 AM
VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM